UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 92

Sortiert nach

Unraveling pathologies underlying chromosomal instability in cancers

Cancer science, 2021-08, Vol.112 (8), p.2975-2983

2021

Link zum Volltext

Verfügbarkeit prüfen

Chromosome arm length, and a species-specific determinant, define chromosome arm width

Cell reports (Cambridge), 2022-12, Vol.41 (10), p.111753-111753, Article 111753

2022

Link zum Volltext

Verfügbarkeit prüfen

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)

Supportive care in cancer, 2020-02, Vol.28 (2), p.571-579

2020

Link zum Volltext

Verfügbarkeit prüfen

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

BMC cancer, 2021-04, Vol.21 (1), p.358-358, Article 358

2021

Link zum Volltext

Verfügbarkeit prüfen

Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study

International journal of hematology, 2020-04, Vol.111 (4), p.567-573

2020

Link zum Volltext

Verfügbarkeit prüfen

Myelomatous meningitis: a case report

International journal of hematology, 2016-08, Vol.104 (2), p.149-150

2016

Link zum Volltext

Verfügbarkeit prüfen

Epstein-Barr virus gastric ulcer associated with ruxolitinib

Annals of hematology, 2016-10, Vol.95 (10), p.1741-1742

2016

Link zum Volltext

Verfügbarkeit prüfen

MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era

Leukemia research, 2020-10, Vol.97, p.106426, Article 106426

2020

Link zum Volltext

Verfügbarkeit prüfen

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib

Annals of hematology, 2016-09, Vol.95 (9), p.1561-1562

2016

Link zum Volltext

Verfügbarkeit prüfen

Serum Cell-Free DNA Concentration Is Predictive of Survival Outcomes and Its Genetic Mutation Analysis May Be Viable in Obtaining Pathological Information

Blood, 2019-11, Vol.134 (Supplement_1), p.1498-1498

2019

Link zum Volltext

Verfügbarkeit prüfen

Cell-Free DNA Genotyping Analysis in Diffuse Large B-Cell Lymphoma; The Correlation between TP53 Gene Mutation and Cereblon Gene Mutation

Blood, 2019-11, Vol.134 (Supplement_1), p.2786-2786

2019

Link zum Volltext

Verfügbarkeit prüfen

The Necessary for Long-Term Follow-up of Mutated Genes and Clonal Evolutions in Multiple Myeloma Combined with cfDNA Assay

Blood, 2019-11, Vol.134 (Supplement_1), p.5515-5515

2019

Link zum Volltext

Verfügbarkeit prüfen

Outcomes of primary and secondary breast diffuse large B-cell lymphoma in rituximab-era

Annals of oncology, 2018-10, Vol.29, p.vii59-vii59

2018

Link zum Volltext

Verfügbarkeit prüfen

Acquired Chromosomal Abnormalities t(14;16), Del(17p) or Del(13q) after Receiving Chemotherapies Predict the Poor Prognosis of Multiple Myeloma

Blood, 2017-12, Vol.130, p.3116-3116

2017

Link zum Volltext

Verfügbarkeit prüfen

Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD5+DLBCL

British journal of haematology, 2018-11, Vol.183 (4), p.661-664

2018

Link zum Volltext

Verfügbarkeit prüfen

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

Blood, 2018-11, Vol.132 (Supplement 1), p.2989-2989

2018

Link zum Volltext

Verfügbarkeit prüfen

B-Symptoms, Performance Status and Response to First Therapy As Survival Predictive Factors for Peripheral T-Cell Lymphoma at Progression/Relapse: A Single Institute Analysis

Blood, 2018-11, Vol.132 (Supplement 1), p.5360-5360

2018

Link zum Volltext

Verfügbarkeit prüfen

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

Blood, 2018-11, Vol.132 (Supplement 1), p.5417-5417

2018

Link zum Volltext

Verfügbarkeit prüfen

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Blood, 2018-11, Vol.132 (Supplement 1), p.4242-4242

2018

Link zum Volltext

Verfügbarkeit prüfen

Efficacy of Rituximab Maintenance for Diffuse Large B Cell Lymphoma with Transformation

Blood, 2018-11, Vol.132 (Supplement 1), p.4229-4229

2018

Link zum Volltext

Verfügbarkeit prüfen

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

Blood, 2018-11, Vol.132 (Supplement 1), p.5399-5399

2018

Link zum Volltext

Verfügbarkeit prüfen

Gastric involvement, a rare site for extramedullary myeloma

Annals of hematology, 2016-03, Vol.95 (4), p.663-664

2016

Link zum Volltext

Verfügbarkeit prüfen

Azacytidine is effective in the therapy related myelodysplastic syndrome

Annals of oncology, 2017-10, Vol.28 Suppl 9, p.ix82

2017

Link zum Volltext

Verfügbarkeit prüfen

Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD 5 + DLBCL

British journal of haematology, 2018-11, Vol.183 (4), p.661-664

2018

Link zum Volltext

Verfügbarkeit prüfen

Azacitidin Is Effective in the Therapy Related Myelodysplastic Syndrome

Blood, 2016-12, Vol.128 (22), p.5554-5554

2016

Link zum Volltext

Verfügbarkeit prüfen

1 – 25 von 92

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(83)
Mit Volltextzugriff
(82)

Publikationsform

Artikel
(90)
Berichte
(2)

Sprache

Englisch
(87)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

Science & Technology
(41)
Life Sciences & Biomedicine
(35)
Humans
(26)
Male
(19)
Female
(17)
Middle Aged
(14)
Oncology
(13)
Aged
(11)
Medicine
(11)
Medicine & Public Health
(11)
Retrospective Studies
(11)
Hematology
(10)
Treatment Outcome
(10)
Antineoplastic Combined Chemotherapy Protocols - Therapeutic Use
(7)
Chemotherapy
(7)
Ligaments
(7)
Original Article
(7)
Patients
(7)
Spinal Cord
(7)
Adult
(6)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Unraveling pathologies underlying chromosomal instability in cancers

Chromosome arm length, and a species-specific determinant, define chromosome arm width

Incidence and risk factors for febrile neutropenia in Japanese patients with non-Hodgkin B cell lymphoma receiving R-CHOP: 2-year experience in a single center (STOP FN in NHL 2)

Factors for the optimal selection of granulocyte colony-stimulating factor preparations and predictors for R-CHOP dose reductions/delays among patients with non-Hodgkin B-cell lymphoma (STOP FN in NHL 2 subanalysis)

Insignificance of surveillance imaging in patients with diffuse large B-cell lymphoma who achieved first complete remission: a retrospective cohort study

Myelomatous meningitis: a case report

Epstein-Barr virus gastric ulcer associated with ruxolitinib

MYD88 L265P mutation detected by digital PCR as a prognostic factor in patients with diffuse large B-cell lymphoma in rituximab era

Klebsiella pneumoniae primary liver abscess associated with ruxolitinib

Serum Cell-Free DNA Concentration Is Predictive of Survival Outcomes and Its Genetic Mutation Analysis May Be Viable in Obtaining Pathological Information

Cell-Free DNA Genotyping Analysis in Diffuse Large B-Cell Lymphoma; The Correlation between TP53 Gene Mutation and Cereblon Gene Mutation

The Necessary for Long-Term Follow-up of Mutated Genes and Clonal Evolutions in Multiple Myeloma Combined with cfDNA Assay

Outcomes of primary and secondary breast diffuse large B-cell lymphoma in rituximab-era

Acquired Chromosomal Abnormalities t(14;16), Del(17p) or Del(13q) after Receiving Chemotherapies Predict the Poor Prognosis of Multiple Myeloma

Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD5+DLBCL

The Role of Image Surveillance in Patients with Diffuse Large B-Cell Lymphoma: A Single-Center Validation Study

B-Symptoms, Performance Status and Response to First Therapy As Survival Predictive Factors for Peripheral T-Cell Lymphoma at Progression/Relapse: A Single Institute Analysis

The Prognosis of Transformed DLBCL Were Superior to De Novo DLBL after the Relapsed/Refractory Status Related to the MYC Translocation

The Prognostic Significance of Soluble Interleukin-2-Receptor, Beta-2-Microgrobulin and Serum Albumin in Patient with Diffuse Large B-Cell Lymphoma in the Rituximab Era

Efficacy of Rituximab Maintenance for Diffuse Large B Cell Lymphoma with Transformation

Impact of Creatinine Clearance in Patients with Diffuse Large B-Cell Lymphoma Treated with R-CHOP : A Real-World Long-Term Observation Analysis at a Single Institute

Gastric involvement, a rare site for extramedullary myeloma

Azacytidine is effective in the therapy related myelodysplastic syndrome

Bearing 19q13 aberration predicts poor prognosis in non‐germinal centre type of CD 5 + DLBCL

Azacitidin Is Effective in the Therapy Related Myelodysplastic Syndrome

Suchergebnisse filtern